Celebrating Bipartisan Congressional Leadership on the Global Fund
Fiscal Year 2025 Investment Case
New Report: Global Fund Partnership Has Saved 65 Million Lives Since 2002
Report: Expanding the HIV Response to Drive Broad-Based Health Gains
Video: The Central Role of Health Systems in Pandemic Preparedness
Subscribe to receive updates
The Global Fund to Fight AIDS, Tuberculosis and Malaria: A smart, lifesaving U.S. investment
decline in combined death rate from AIDS, TB and malaria
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA
Is the world’s largest global health funder
Invests more than $5 billion a year in programs run by local experts and governments
Builds stronger health systems, health security and pandemic preparedness
Accelerates the end of the world’s deadliest infectious diseases
FEATURED
Ending AIDS
Translating Progress into Success to End the AIDS Epidemic is a collaboration between amfAR, AVAC, and Friends of the Global Fight, with technical assistance from the Henry J. Kaiser Family Foundation. The report was conceptualized to take stock of how far we have come – and how far we have to go – toward ending HIV and AIDS around the world.
Ending TB
TB is curable. We need renewed and sustained political will to combat this epidemic. We know we can end the TB epidemic. It is a matter of scaling up effective programs, dedicating sufficient resources and mobilizing the political will. This report highlights six locations where communities made impressive progress to significantly reduce TB cases and deaths – from California in the United States to Tomsk, Russia and Karachi, Pakistan.
Ending Malaria
In the last two decades, global efforts against malaria have reached a tipping point, allowing health leaders for the first time to move beyond merely controlling this ancient disease and instead commit to ending it.
RECENT NEWS
Market Shaping: How the Global Fund is Saving Lives and Delivering on the Future of Health
As the largest financier of HIV, TB and malaria programs in low- and middle-income countries, the Global Fund leverages its scale to secure improved supply terms, ensure supply reliability and foster innovations that are accessible to all. These market shaping interventions make health products more affordable and accessible in low- and middle-income countries. This new slide deck…
Friends Welcomes Dr. Raj Panjabi to Its Board of Directors
Friends Welcomes Dr. Raj Panjabi to Its Board of Directors Friends is thrilled to announce that Dr. Raj Panjabi has joined its Board of Directors. Dr. Panjabi is currently Senior Partner at Flagship Pioneering and on the faculty at Harvard Medical School and Brigham and Women’s Hospital. Among his many other roles, he previously led the U.S. President’s Malaria Initiative. In that position,…
Friends Board Member Receives Prestigious Lasker-Bloomberg Award for HIV Leadership
Friends Board Member Receives Prestigious Lasker-Bloomberg Award for HIV Leadership Washington, DC – Friends board member Dr. Quarraisha Abdool Karim has been honored with the Lasker-Bloomberg Public Service Award for her contribution to combating the spread of HIV/AIDS and for transformative public health advocacy and programming throughout Africa and globally. She received the award alongside…
Comments by Chris Collins at National Academy of Medicine Workshop on HIV-AIDS Sustainability
Comments by Chris Collins at National Academy of Medicine Workshop on HIV-AIDS Sustainability The following are comments made by Friends President and CEO Chris Collins during the panel, Sustaining Political Commitment to Ending HIV as a Public Health Threat. It is good we are having this dialogue as political leaders on the hill want to…
New report: Global Fund partnership has saved 65 million lives since 2002
New report: Global Fund partnership has saved 65 million lives since 2002 2023 was a year of important progress in the fight against HIV, TB and malaria. Report finds reduced HIV incidence in adolescent girls and young women; increased use of innovative new tools to treat TB and malaria; broader health systems cost savings; treatment…